Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice M Calderón-Goercke, J Loricera, V Aldasoro, S Castañeda, I Villa, ... Seminars in arthritis and rheumatism 49 (1), 126-135, 2019 | 115 | 2019 |
Listeria monocytogenes infection in patients with rheumatic diseases on TNF-alpha antagonist therapy: the Spanish Study Group experience JL Peña-Sagredo, MV Hernández, N Fernandez-Llanio, ... Clinical & Experimental Rheumatology 26 (5), 854, 2008 | 81 | 2008 |
Tocilizumab in giant cell arteritis: differences between the GiACTA trial and a multicentre series of patients from the clinical practice MAG Gay, M de Valdecilla Clin Exp Rheumatol 38, 124, 2020 | 31 | 2020 |
Demyelinating disease and cutaneous lymphocitic vasculitis after etanercept therapy in a patient with rheumatoid arthritis VM Martínez‐Taboada, JF Val‐Bernal, LC Pesquera, ... Scandinavian journal of rheumatology 35 (4), 322-323, 2006 | 15 | 2006 |
Demyelinating disease and cutaneous lymphocitic vasculitis after etanercept therapy in a patient with rheumatoid arthritis VM Martínez‐Taboada, JF Val‐Bernal, LC Pesquera, ... Scandinavian journal of rheumatology 35 (4), 322-323, 2006 | 15 | 2006 |
Increased interferon-1α, interleukin-10 and BLyS concentrations as clinical activity biomarkers in systemic lupus erythematosus MF Matilla, EG García, NFL Comella, IC Verdejo, JI Cortés, JAC Cuesta, ... Medicina Clínica (English Edition) 153 (6), 225-231, 2019 | 9 | 2019 |
Tocilizumab in refractory Caucasian Takayasu’s arteritis: a multicenter study of 54 patients and literature review D Prieto-Peña, P Bernabeu, P Vela, J Narváez, JC Fernández-López, ... Therapeutic Advances in Musculoskeletal Disease 13, 1759720X211020917, 2021 | 7 | 2021 |
Bosentan therapy for cutaneous fibrosis in systemic sclerosis JJ Alegre-Sancho, JA Roman-Ivorra, C Chalmeta-Verdejo, ... Current Medical Research and Opinion 23 (sup2), S89-S96, 2007 | 6 | 2007 |
Sindrome De Churg-Strauss JAC Cuesta, JG Domínguez, NFL Comella Revista de la SVR: Sociedad Valenciana de Reumatología 4 (2), 17-26, 2011 | 5 | 2011 |
AB0577 TOCILIZUMAB IN GIANT CELL ARTERITIS. ROUTE OF ADMINISTRACION: INTRAVENOUS OR SUBCUTANEOUS M Calderón-Goercke, J Loricera, D Prieto-Pena, V Aldasoro, S Castañeda, ... Annals of the Rheumatic Diseases 78 (Suppl 2), 1750-1750, 2019 | 4 | 2019 |
Terapias hormonales, fertilidad y embarazo en el síndrome antifosfolipídico N Fernández-Llanio, JJ Alegre-Sancho, C Chalmeta-Verdejo, ... Reumatología Clínica 2 (2), 90-106, 2006 | 4 | 2006 |
Long-term efficacy and safety of bosentan in the treatment of ischemic digital ulcers due to severe Raynaud's phenomenon in patients with systemic sclerosis JJ Alegre-Sancho, N Fernandez-Llanio, R Hortal-Alonso, S Muñoz-Gil, ... ANNALS OF THE RHEUMATIC DISEASES 64, 287-287, 2005 | 4 | 2005 |
Esclerosis sistémica JJA Sancho, EB Catalán, IC Verdejo, NF Llanio, JI Cortés, JAR Ivorra Belmonte MA, Castellano JA, Román JA, Rosas JC. Enfermedades reumáticas …, 2015 | 3 | 2015 |
Poliartritis aguda por parvovirus B19 JMS Gallego, NFL Comella, SM Gil, CC Verdejo, JJA Sancho Revista de la SVR: Sociedad Valenciana de Reumatología 2 (1), 24-26, 2006 | 3 | 2006 |
OP0339 TOCILIZUMAB IN GIANT CELL ARTERITIS. MONOTHERAPY VERSUS COMBINED WITH CONVENTIONAL IMMUNOSUPPRESSIVE DRUGS M Calderón-Goercke, J Loricera, D Prieto-Peña, V Aldasoro, S Castañeda, ... Annals of the Rheumatic Diseases 78 (Suppl 2), 252-253, 2019 | 2 | 2019 |
AB0058 Il2 decrease and increase of il10 and inf1a are associated to clinical activity in systemic lupus erythematouspatients E Grau, C Feced, E Labrador, FM Ortiz, C Alcañiz, K Arevalo, I Chalmeta, ... Annals of the Rheumatic Diseases 77 (Suppl 2), 1228-1228, 2018 | 2 | 2018 |
THU0229 Dna hypomethylation and decreased hydroxymethylation is associated with decreased antioxidant response in systemic lupus erythematous patients EG Garcia, CMF Olmos, MF Matilla, ES Labrador, FM Ortiz-Sanjuan, ... Annals of the Rheumatic Diseases 76 (Suppl 2), 291-291, 2017 | 2 | 2017 |
AB0482 evaluation of current and at the onset clinical manifestations in systemic lupus erythematosus patients MF Matilla, EG García, GP Marín, CF Olmos, EL Sánchez, FMO Sanjuan, ... Annals of the Rheumatic Diseases 75 (Suppl 2), 1071-1071, 2016 | 2 | 2016 |
Miopatías inflamatorias idiopáticas JI Cortés, E Quecedo, IC Verdejo, NF Llanio, EB Catalán, JJA Sancho, ... Enfermedades reumáticas. Actualización SVR., 239-6.3, 2013 | 2 | 2013 |
Vitamin D status in osteoporotic postmenopausal women taking oral recommended vitamin D supplementation J Ivorra, E Valls, C Verdejo, OO MJ, RI JA Medicina Clinica 138 (5), 199-201, 2011 | 2 | 2011 |